Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Juni 2014 16:05 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals to Present at 9th Annual JMP Securities Healthcare Conference

BERKELEY HEIGHTS, N.J., June 17, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
31. Mai 2014 21:00 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Provides Update on Its Clinical Development Plan of Sapacitabine for Myelodysplastic Syndromes (MDS)

BERKELEY HEIGHTS, N.J., May 31, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
28. Mai 2014 07:00 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals to Webcast Institutional Investor and Analyst Presentation on Clinical Development Plan of Sapacitabine for MDS

BERKELEY HEIGHTS, N.J., May 28, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
13. Mai 2014 16:05 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Reports First Quarter 2014 Financial Results

BERKELEY HEIGHTS, N.J., May 13, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
06. Mai 2014 16:05 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals to Release 2014 First Quarter Financial Results

BERKELEY HEIGHTS, N.J., May 6, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies...
05. Mai 2014 07:00 ET | Quelle: Bio Green Med Solution, Inc.

New Japanese Patents Issued Covering Sapacitabine Pharmaceutical Formulations and Combination Treatments

BERKELEY HEIGHTS, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced that the Japanese Patent and Trademark...
10. April 2014 07:00 ET | Quelle: Bio Green Med Solution, Inc.

Independent Investigators Present Non-Clinical Data Providing Rationale for Sapacitabine Combination Treatment With Bcr-Abl Inhibitors in CML

BERKELEY HEIGHTS, N.J., April 10, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
09. April 2014 16:05 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals, Inc. Announces Closing of $10 Million Underwritten Offering

BERKELEY HEIGHTS, N.J., April 9, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company) today announced that it has closed the previously...
04. April 2014 07:00 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Announces $10 Million Underwritten Offering

BERKELEY HEIGHTS, N.J., April 4, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company) today announced the pricing of an underwritten public...
03. April 2014 16:20 ET | Quelle: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock

BERKELEY HEIGHTS, N.J., April 3, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company) today announced that it intends to offer, subject to...

Vorherige Seite